Reports of unusual blood clots in the setting of low platelets associated with COVID-19 vaccines have brought attention to these tiny cell fragments tasked with preventing humans from fatally bleeding ...

Essential thrombocythemia (ET) is a type of myeloproliferative neoplasm (MPN), a rare blood disorder that causes an increase in the number of blood cells. Some symptoms include headaches, dizziness, ...

Patients with ET experience diagnostic delays, averaging 26.5 months from the first elevated platelet count to diagnosis, indicating potential underestimation of the disease's burden. The study ...

Research has proven frozen blood platelets are safe and effective for use in critically injured patients—a breakthrough dramatically extending their shelf life for transfusions from one week to two ...

Promacta tended to boost platelet counts in patients with low-risk MDS, and helped those patients be independent of transfusions, too. Promacta (eltrombopag) improved platelet counts in patients with ...